ABCD News

Most read articles by the same author(s)

• Umesh Dashora, Andrew Macklin, Bob Ryder, Erwin Castro, ABCD Nationwide U-500 Audit Contributors, Clinical use of Humulin R U-500 insulin in the UK: results of the first Association of British Clinical Diabetologists’ U-500 audit , British Journal of Diabetes: Vol. 16 No. 4 (2016)
• Tom Crabtree, Karen Adamson, Alex Bickerton, Alison Evans, Suzanne Phillips, Alison Gallagher, Niels Larsen, Dennis Barnes, Ketan Dhatariya, Benjamin CT Field, Iskander Idris, Robert EJ Ryder, The factors predicting glucose and weight response to injectable semaglutide (Ozempic): real-world data from the Association of British Clinical Diabetologists’ audit programme , British Journal of Diabetes: Vol. 23 No. 2 (2023): December 2023
• Umesh Dashora, Dipesh C Patel, Robert Gregory, Peter Winocour, Ketan Dhatariya, Dinesh Nagi, Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019) , British Journal of Diabetes: Vol. 19 No. 1 (2019): June 2019
• Umesh Dashora, Alban Davies Huw, Shelley Bennett, Anne Goodchild, Julia Hugason-Briem, Gail Johnson, Abigail Kitt, Annette Schreiner, Diane Todd, Jennifer Yiallorous, Findings of a nationwide survey of the diabetes education and training needs of midwives in the UK , British Journal of Diabetes: Vol. 18 No. 4 (2018): October / November / December 2018
• Umesh Dashora, Erwin Castro, Insulin U100, 200, 300 or 500? , British Journal of Diabetes: Vol. 16 No. 1 (2016)
• Ketan Dhatariya, Peter Winocour, Andrew Raffles, A survey of the management of 16–18-year-olds presenting with diabetic ketoacidosis in the UK: a need for standardisation , British Journal of Diabetes: Vol. 19 No. 1 (2019): June 2019
• Umesh Dashora, Alison Gallagher, Ketan Dhatariya, Peter Winocour, Rob Gregory, On Behalf of the ABCD Committee, Association of British Clinical Diabetologists (ABCD) position statement on the risk of diabetic ketoacidosis associated with the use of sodium-glucose cotransporter-2 inhibitors , British Journal of Diabetes: Vol. 16 No. 4 (2016)
• Kate West, Lucy-Anne Webb, Matthew Fenech, Ketan Dhatariya, Possible risk factors for the development of sodium-glucose co-transporter 2 inhibitor- associated diabetic ketoacidosis in type 2 diabetes , British Journal of Diabetes: Vol. 16 No. 2 (2016)
• Dinesh Kumar Nagi, Susannah Rowles, Andrew Macklin, Umesh Dashora, Heather Oliver, Dipesh Patel, Integrated diabetes care: The Association of British Clinical Diabetologists (ABCD) national survey report , British Journal of Diabetes: Vol. 21 No. 2 (2021): December 2021
• Thomas SJ Crabtree, Ralph A DeFronzo, Robert E J Ryder, Clifford J Bailey, Imeglimin, a novel, first in-class, blood glucose-lowering agent: a systematic review and meta-analysis of clinical evidence , British Journal of Diabetes: Vol. 20 No. 1 (2020): June 2020